諾華藥廠 NVS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 137.87 | 18.92 | 1.25 | 3,616,000 | 2,409 | |
| 2025Q3 | 128.24 | 18.55 | 2.02 | 4,501,000 | 3,928 | |
| 2025Q2 | 121.01 | 18.59 | 2.06 | 4,864,000 | 4,041 | |
| 2025Q1 | 111.48 | 17.12 | 1.82 | 4,663,000 | 3,606 | |
| 2024Q4 | 97.31 | 16.66 | 1.41 | 3,530,000 | 2,818 | |
| 2024Q3 | 115.02 | 13.36 | 1.57 | 3,627,000 | 3,189 | |
| 2024Q2 | 106.46 | 14.27 | 1.59 | 4,014,000 | 3,246 | |
| 2024Q1 | 96.73 | 13.31 | 1.31 | 3,373,000 | 2,688 | |
| 2023Q4 | 100.97 | 27.31 | 4.11 | 2,582,000 | 8,480 | |
| 2023Q3 | 101.86 | 28.23 | 0.85 | 1,762,000 | 1,761 | |
| 2023Q2 | 100.91 | 27.97 | 1.11 | 2,807,000 | 2,316 | |
| 2023Q1 | 92.00 | 27.75 | 1.08 | 2,618,000 | 2,293 | |
| 2022Q4 | 90.72 | 8.95 | 0.68 | 1,949,000 | 1,466 | |
| 2022Q3 | 76.01 | 7.61 | 0.72 | 2,168,000 | 1,573 | |
| 2022Q2 | 84.53 | 8.14 | 0.77 | 2,228,000 | 1,694 | |
| 2022Q1 | 87.75 | 8.11 | 0.99 | 2,852,000 | 2,222 | |
| 2021Q4 | 87.47 | 8.15 | 7.24 | 2,562,000 | 16,308 | |
| 2021Q3 | 81.78 | 18.65 | 1.22 | 3,233,000 | 2,758 | |
| 2021Q2 | 91.24 | 22.80 | 1.28 | 3,479,000 | 2,896 | |
| 2021Q1 | 85.48 | 24.25 | 0.91 | 2,415,000 | 2,059 |